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ABSTRACT 
This study reports the isolation and characterization of six new acremine metabolites, 5-
chloroacremine A (4), 5-chloroacremine H (5), acremines O (6), P (7), Q (8), and R (9), 
together with the known acremines A (1), F (2), and N (3) from the fungus Acremonium 
persicinum cultured from the marine sponge Anomoianthella rubra. The relative 
configuration of acremine F (2) was determined by analyses of proton coupling constant 
values and NOESY data, and the absolute configuration confirmed as (1S, 4S, 6R) by X-ray 
crystallographic analysis of the borate ester derivative 15. Acremines O, P and R were each 
shown to be of 8R configuration by 1H NMR analyses of MPA esters. The relative 
configurations suggested for acremines P and Q were each deduced by molecular modeling 
together with NOESY and coupling constant data. The 3JH-C values in acremine P were 
measured using the pulse sequence EXSIDE, and the observed 3JH8-C4 of 5.4 Hz and small 
3JH-C values (<1.5 Hz) to C-10 and C-11 were fully consistent with stereoisomer 7a. For 
acremine Q, NOESY data combined with molecular modeling established the preferred 
diastereomer 8a.   
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Fungi from the genus Acremonium have been reported from both terrestrial1-3 and marine 
sources4-6 and produce unique and biologically active secondary metabolites, the most well 
known being the antibiotic cephalosporin C.7 Antioxidant hydroquinone derivatives8 and a 
chlorinated polyketide6 have been reported from an algal-derived Acremonium sp., while 
isolates derived from marine sponges have yielded alkaloids,4,9 peptides,10,11 or oxygenated 
metabolites.12  
In 2005, Nasini et al. reported a series of 12 meroterpenoids, including acremines A 
(1), F (2), and N (3), from an endophytic strain of Acremonium byssoides isolated from 
sporangiospores of Plasmopara viticola in grapevine leaves.1,13,14 Malik et al. described the 
isolation of a “norterpenoid” from the plant Periploca aphylla,15 however the structure of this 
compound was later revised to that of acremine A (1) based on a synthetic study.16 Acremine 
A has also been isolated from the fungus Myceliopthora lutea by Smetanina et al. along with 
isoacremine D and two spiroacremines.17 Although the structure and 1H NMR data of 
isoacremine D reported by the Russian group were identical to those of acremine D described 
by the Italian researchers,1 the 13C NMR and melting point data of the two samples differed. 
Recently, total syntheses of acremines A, B, and I have been developed by Mehta et al.18  
In this report, we describe the isolation, structure elucidation, and configurations of 
six new acremines (4 - 9) along with the known acremines A (1), F (2), and N (3). 
Identification of the ether product 10 as well as the known spiroacremines A (11) and B (12) 
during the course of the chromatographic purification highlights the sensitivity of the 
oxygenated cyclohexenone/cyclohexenediol ring systems to the isolation conditions used.  
 
RESULTS AND DISCUSSION 
Structural and Stereochemical Studies. The sponge Anomoianthella rubra was 
collected in December 2009 by SCUBA from the Gneering reef offshore from Mooloolaba in 
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South East Queensland. Colonies of Acremonium persicinum were successfully cultured by 
streaking small pieces of sterilized sponge sample onto malt extract and potato dextrose agar 
media made up in artificial seawater. Identification of the isolate was undertaken by 
performing colony PCR of the rDNA ITS followed by DNA sequencing. Following 
preliminary investigation of a small scale culture, large scale fermentation was carried out in 
malt extract media (4 L) made up in artificial sea water. After 4 weeks, the culture broth was 
extracted with EtOAc followed by n-BuOH to afford extracts from which six new acremine 
metabolites (4-9) were isolated together with 9-O-methyl-acremine F (10), and 
spiroacremines A (11) and B (12) in addition to the known acremines A (1), F (2), and N (3). 
 
 
 
 
 
 
 
 
The 1H and 13C NMR data (Tables 1 and 2) for acremine A (1), the major component 
in the extract, are reported in CDCl3, while the 1H NMR spectrum was also measured in 
acetone-d6 for direct comparison with literature data. Nasini et al. determined the relative 
configuration of 1 by X-ray crystallographic analysis, while the absolute configuration was 
deduced as (4S, 6R) following Mosher esterification.1 The specific rotation of 1 from A. 
persicinum was measured as +13 compared to a literature value of + 22.3, consistent with a 
(4S, 6R) configuration. 
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Table 1. 1H NMR Assignments for Acremines 1, 2, 4-9a,b 
Position 1 2 4 5 6 7 8 9 
1  4.00, dd (8.5, 2.5)       
2 
  
6.00, br s 5.61, d (2.5) 6.18, d (1.8) 6.13, t (1.5, 1.0) a) 3.26, d (16.1) 
b) 3.02, d (16.1) 
5.20, s a) 2.90, dd (16.0, 7.5) 
b) 1.98, dd (16.0, 6.0) 
6.49, s 
3       2.73, m  
4 4.63, m 4.43, m 4.60, m 4.78, m     
5  
 
a) 2.36, dd (13.0, 5.1) 
b) 2.10, dd (13.0, 8.8) 
a) 2.24, dd (14.5, 2.0) 
b) 1.80, dd (14.5, 4.0) 
4.23, d (8.2) 
 
4.21, d (5.7) 
 
 
 
3.57, s 
 
3.51, s 
 
6.61, s 
 
7 6.44, d (16.0) 6.19, d (16.0) 6.49, d (16.0) 3.94, ddd (2.0, 1.0, 0.5) a) 3.01, dd (13.7, 5.8) 
b) 1.84, dd (13.7, 4.0) 
5.83, br d (8.8) a) 2.34, ddd (13.1, 7.4, 7.0) 
b)1.54c 
a) 2.99, dd (16.8, 5.0) 
b) 2.69, dd (16.8, 5.0) 
8 6.67, d (16.0) 6.08, d (16.0)  6.70, d (16.0) 2.99, d (2.0) 4.15, dt (5.8, 4.0) 4.15, s 3.98, t (7.0) 3.73, dt (8.0, 5.0) 
10 1.35, s 1.36, s 1.404, s 1.36, s 1.27, s 1.47, s 1.32, s 1.34, s 
11 1.35, s 1.35, s 1.400, s 1.31, s 1.16, s 1.43, s 1.14, s 1.27, s 
12 1.30, s 1.32, s 1.39, s 1.58, s 2.16, s 1.51, s 1.44, s 2.17, s 
1-OH  2.65, d (8.5)      4.33, s 
4-OH 2.96, br d (6.5) 3.42, d (7.0) 2.90, d (4.8) 2.79, d (4.9)     
6-OH 3.41, s 3.44, br s       
7-OH      3.17, d (8.8)   
8-OH        1.75, d (8.0) 
a Chemical shifts (ppm) referenced to CHCl3 (δH 7.26). b At 500 MHz. c Obscured by H2O peak, assigned by DQFCOSY. 
 
Table 2. 13C NMR Assignments for Acremines 1, 2, 4-9a,b 
Position 1 2 4 5 6 7 8 9 
1 200.1 73.0 198.3 195.5 192.6 192.3  205.3  147.8  
2 123.1 130.2 121.5 122.2 51.3 102.4  38.9  115.6  
3 157.9 137.7 156.2 155.7 83.4 162.5  43.7 116.8  
4 65.6 64.1 72.2 70.5 189.1 99.0  102.7 146.3  
5 43.9 40.5 70.4 69.6 144.8 59.1 66.0 119.2  
6 73.1 71.1 75.9 75.2 147.8 57.4 60.7 123.7  
7 124.3 126.2 122.7 53.0 40.1 95.0 31.7 31.3  
8 147.1 138.4 149.2 67.9 78.0 86.2 86.2 69.8  
9 71.4 71.1 71.3 67.9 86.6 78.2 71.3 76.3 
10 29.8 30.1 29.6 27.5 22.8 25.8 27.7 22.6 
11 29.8 29.7 29.6 25.0 26.8 23.4 25.3 24.5 
12 24.1 26.8 21.0 23.7 14.8 14.5 14.7 15.7 
a Chemical shifts (ppm) taken from 2D spectra referenced to CDCl3 (δC 77.16). b At 500 MHz. 
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A full NMR assignment of acremine F (2) was undertaken using HSQC and HMBC 
experiments as the 13C NMR data were not available from the literature. The signals for H-7 
and H-8 were observed at δH 6.19 and 6.08, respectively; on this basis the literature 
assignments for H-7 (δH 6.09) and H-8 (δH 6.17) should be reversed. The specific rotation of 
2 from A. persicinum was +38 compared to a value of +56 reported in the literature. However 
in this previous work, the relative configuration at C-1 of acremine F was not defined.1 
Treatment of acremine A (1) with NaBH4 in EtOH gave a mixture of two compounds in a 2:1 
ratio that were separated by RP HPLC using 15% MeCN/H2O as eluent. The 1H NMR 
spectrum of the major compound, which eluted second from the RP HPLC column, was 
identical to that of acremine F. The minor compound shared similar 1H NMR features to 
those of acremine F, except for the H-2 signal (δH 5.88 (J = 4.8 Hz) vs. δH 5.61 (J = 2.5 Hz) 
in acremine F), and was assigned as the C-1 epimer of acremine F (13). 
 
Figure 1. a, Cyclohexene ring conformers for acremine F (2) and 1-epi-acremine F (13) (R = 
sidechain); b, Energy-minimized model structures of 2a and 13a showing NOESY 
correlations observed for 2 and 13.  
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The conformational equilibria for acremine F (2) and 1-epi-acremine F (13) are 
considered in Figure 1a. Individual conformers (2a/b, 13a/b) were modeled using 
ChemBio3D Ultra 12.0 (Cambridge), and by applying the MM2 force field for energy 
minimization to an RMS gradient of 0.100. In acremine F (2), the experimental coupling 
constant values for H-1/H-2, H-4/H-5a, and H-4/H-5b (2.5, 2.0, and 4.0 Hz) were in 
agreement with theoretical values anticipated for conformer 2a (see Table S1 in Supporting 
Information), and placed H-1 and H-4 in pseudo-axial and pseudo-equatorial orientations, 
respectively. Consistent with this interpretation, 1D-NOESY irradiation of the proton signal 
at δH 4.00 (H-1) of 2 led to enhancement of H-2, H-5b, and Me-12 (Figure 1b). For 1-epi-
acremine F (13), the experimental J values of 4.8, 4.4 and 3.3 Hz for H-1/H-2, H-4/H-5a and 
H-4/H-5b matchedtheoretical values anticipated for conformer 13a in which both H-1 and H-
4 were pseudo-equatorial. 1D NOESY irradiation of the signal at δH 3.92 (H-1) of 13 led to 
enhancement of H-2 and Me-12, but there was no enhancement of a C-5 proton. A coupling 
of 1.1 Hz between H-1 and H-5b confirmed the equatorial orientation of H-5b. In both 
acremine F and 1-epi-acremine F, conformers with a cis-1,3-pseudoaxial-axial arrangement 
between the C-4 and C-6 hydroxy groups were thus favored. In cyclic organic compounds 
with a cis-1,3-arrangement of hydroxy groups, the diequatorial conformer is preferred in 
polar solvents but the diaxial conformer becomes an important contributor to the overall 
conformational equilibrium in non-polar solvents owing to the intramolecular hydrogen 
bonding between the two hydroxy groups.19 In both 2a and 13a there is also the stabilizing 
feature of an equatorial Me group at C-6. 
The relative and absolute configurational features of 2 were confirmed by an X-ray 
crystallographic study conducted on a derivative prepared from 9-O-methyl-acremine F (10). 
For ether 10, a sodiated ion peak at m/z 265.1422 provided the molecular formula C13H22O4. 
The 1H NMR data were very similar to those of 2, except for a singlet at δH 3.16 (3H) which 
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gave HMBC correlations to the methyl groups at C-10 and C-11, as well as to C-9, and so 
revealed that a methoxy group had replaced the hydroxy group at C-9. On exposure to mildly 
acidic conditions during isolation, acremine F (2) may form a stable tertiary allylic 
carbocation at C-9, which then reacts with methanol to form 10. Treatment of 10 with p-
bromophenylboronic acid (1.1 equiv.) in CH2Cl2 for 24h gave a mixture of products, 
including the desired p-bromophenylboronate ester 14. Recrystallization of the ester mixture 
from EtOAc gave single crystals highly suitable for X-ray analysis, except that these 
corresponded to the borate ester 15 rather than 14. In its 1H NMR spectrum, 15 lacked signals 
associated with a phenyl moiety while the mass spectrum exhibited an adduct ion at m/z 
291.1350 [M+Na]+ for the molecular formula C13H21BO5. Boric acid is commonly found as a 
contaminant in commercial samples of boronic acid and related substances.20 The absolute 
configuration of 15 was determined by the anomalous dispersion method on a highly 
redundant data set collected with Cu-Kα radiation and confirmed a (1S, 4S, 6R) configuration 
(Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. ORTEP view of borate ester 15 showing 
absolute and relative configuration. 
 
5-Chloroacremine A (4) and 5-chloroacremine H (5) were obtained from RP-HPLC as 
a mixture in a 1:1 ratio; ESI-MS suggested a mixture of chlorinated compounds from the ion 
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clusters at m/z 283/285 and at m/z 299/301, each with an intensity ratio of 3:1. HRMS 
measurements provided the respective molecular formulae as C12H17ClO4 and C12H17ClO5, 
respectively. The 1H and 13C NMR data of 5-chloroacremine A suggested a substituted 
cyclohexenone ring [δH 6.18 (1H), 4.60 (1H), 4.23 (1H); δC 198.3 (s), 121.5 (d), 156.2 (s), 
72.2 (d), 70.4 (d) and 75.9 (s)] with three methyl groups [δH 1.404, 1.400, 1.39; δC 29.6, 29.6, 
21.0], closely resembling those of 11 except that the methylene group at C-5 was replaced by 
a methine (δH 4.23, δC 70.4). The chlorine substituent was placed at C-5 based on HMBC 
correlations from H-5 to both C-4 (δC 72.2) and C-6 (δC 75.9). The 8.2 Hz coupling between 
H-4 and H-5 established the axial orientation of H-5. In the preferred conformation, the C-6 
hydroxy group is close to coplanar with the adjacent carbonyl group resulting in hydrogen 
bonding (note that this is also the case for acremine A). In the side chain of 4, signals at δH 
6.49 and 6.70, each a doublet with J of 16 Hz, and linked to signals at δC 122.7 and 149.2 by 
HSQC, respectively, confirmed a trans double bond; HMBC correlations from the alkene 
proton at δH 6.70 to C-9, Me-10 and to Me-11 positioned the alkene between C-7 and C-8. 
Based on comparison of its 1H and 13C NMR data with those of 4, 5-chloroacremine 
H (5) was likewise a chlorinated cyclohexenone, however the prenyl side chain contained an 
epoxy group (δH 3.94, 2.99; δC 53.0, 67.9) whose position was determined by HMBC 
correlations from both Me-10 and Me-11 to the epoxy carbon at δC 67.9, as well as from the 
epoxy proton (δH 3.94) to the olefinic carbons (C-2 and C-3). HMBC correlations from the 
methine proton (δH 4.21) to C-1 (δC 195.5), C-3 (δC 155.7), C-4 (δC 70.5) and C-6 (δC 75.2) 
confirmed chlorine substitution at C-5. A 5.7 Hz coupling between H-4 and H-5 established 
the equatorial orientation of H-5. The epoxy protons in 5-chloroacremine H shared a 2.0 Hz 
coupling, closely identical to the value in each of acremines H and L (J = 2.1 Hz),14 which 
supported a trans configuration for the epoxy group. The orientation of the epoxy group 
relative to the stereogenic centres of the cyclohexenone core could not be conclusively 
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determined owing to the small amount of material available; the similarity in the chemical 
shift of H-7 (δH 3.94) to the value of H-7 reported for acremine H (δH 3.93)14 may suggest the 
same diastereomer.     
During NMR analysis of the mixture of 4/5 in CDCl3, it was noticed that the signal 
intensity corresponding to 5-chloroacremine A decreased over time, while signals for a cis 
double bond (δH 5.96 and 5.60, d 5.9 Hz), two methines (δH 4.18 and 3.84), an AB methylene 
(δH 2.94 and 2.60, d 14.4 Hz) appeared. By comparison with data for spiroacremines A (11) 
and B (12), both of which have been identified as artefacts,17 the new product was identified 
as the spiro compound 16. The relative configuration at the spiro centre was not determined 
due to the small amount of material available.  
The final chlorinated compound isolated from the A. persicinum extract was named as 
acremine O (6). The mass spectrum of this compound exhibited a typical ion cluster for a 
chlorinated molecule at m/z 281/283 [M+Na]+ in a ratio of 3:1; a molecular formula of 
C12H15ClO4 was determined by HRESIMS. The 1H NMR spectrum showed signals for one 
oxymethine (δH 4.15), two methylene groups (δH 3.26, 3.02 and δH 3.01, 1.84) and three 
methyl singlets (δH 2.16, 1.27, 1.16). In the 13C NMR spectrum, there were two carbonyl 
groups (δC 189.1, 192.6), while the downfield chemical shift of C-3 (δC 83.4) suggested a 
spiro ring.17 The carbonyl at δC 192.6 was placed at C-1 based on an HMBC correlation to 
Me-12 (δH 2.16), while the carbonyl group at δC 189.1 was assigned to C-4 based on HMBC 
correlations to the methylene protons of C-7. In the side chain, a hydroxy group was placed at 
C-8 based on HMBC correlations from the methyl groups (δH 1.27, 1.16) to C-8 (δC 78.0). As 
in 4 and 5, the chlorine substituent was therefore placed at C-5. The relative configuration of 
the spiro centre followed from NOESY correlations between Me-11/H-8 and Me-11/H-7b 
which suggested that these protons were all on the same face. Similarly, H-2b and H-7a were 
on the same face based on the observed NOESY correlations between these two protons, but 
 11 
opposite to H-8 and Me-11. When 6 was esterified at C-8 to its (R)- and (S)-O-methyl 
mandelate (MPA) esters 17a and 17b, the ∆δRS values (where ∆δRS = δR - δS) were positive 
for H2-2 and H2-7, while negative for Me-10 and Me-11, which was consistent with an 8R 
configuration. The absolute configuration of acremine O is thus (3R, 8R). The natural product 
status of acremine O is unclear.  
A molecular formula of C12H14O6 was determined for acremine P (7) from the adduct 
ion at m/z 277.0673 [M+Na]+. The 1H and 13C NMR spectra supported the presence of a 
substituted cyclohexenone ring [δH 5.20 (1H); δC 192.3 (s), 162.5 (s), 102.4] containing epoxy 
[δH 3.57 (1H); 59.1 (d), 57.4 (s)] and acetal (δC 99.0) groups. Three methyl groups observed 
at δH 1.51, 1.47, and 1.43 were linked to signals at δC 14.5, 25.8 and 23.4 by HSQC, 
respectively, and there were two oxymethines (δH 5.83, 4.15; δC 95.0, 86.2) and one other 
oxygenated carbon (δC 78.2). HMBC correlations from the epoxy proton to C-3 (δC 162.5), C-
4 (δC 99.0), C-6 (δC 57.4) and Me-12 (δC 14.5) secured the position of the epoxy ring between 
C-5 and C-6. Three other signals (H-2, H-7, H-8), as well as Me-12, all showed HMBC 
correlations to the acetal signal at δC 99.0 which was therefore assigned to C-4. A hydroxy 
group (δH 3.17) was located at C-7 from its coupling to H-7 and by HMBC correlations to C-
7 (δC 95.0) and C-8 (δC 86.2), therefore an ether linkage between C-4 and C-8 accounted for 
the HMBC correlation between H-8 and C-4. Based on its molecular formula, acremine P had 
six degrees of unsaturation, of which five had been identified; the oxygen substituents at C-4 
and C-9 were therefore connected to form a peroxy ring, as shown in 7.  
Reduction of 7 under mild conditions (H2, Pd/C, EtOAc, 24 h) gave acremine A (1) as 
the sole product. The specific rotation of the synthetic sample was +25, comparable to the 
value of +13 for the natural isolate from A. persicinum. The absolute configuration at C-7 
was pursued by preparation of the (R) and (S)-O-methyl mandelate (MPA) esters 18a/18b, 
respectively. The ∆δRS values of the MPA esters (where ∆δRS = δR - δS) were positive for H-2 
 12 
and Me-12, and negative for H-8, Me-10 and Me-11, and established a 7R configuration. 
With this information in hand, and recognizing the stereochemical constraint imposed by the  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. a, Structures of candidate diastereomers 7a and 7b for acremine P; b, Energy-
minimized model structures of diastereomers of acremine P showing NOESY correlations for 
preferred conformer 7a. 
 
2,3,8-trioxabicyclo[3.2.1]octane ring system, two candidate diastereomers 7a and 7b (Figure 
3a) were next considered. In the 1H NMR spectrum of 7, the signals for H-2 and H-8 were 
noticeably sharp. The zero coupling between H-7 and H-8 indicated a dihedral angle of 
approx. 90° and so revealed that these two protons were on opposite faces of the ether ring, as 
in 7a rather than 7b. Other pieces of spectroscopic information that pointed to 7a included: 
(i) NOESY correlations from H-8 to H-7, Me-10, and Me-11; (ii) the absence of coupling 
between H-2 and H-7. Also there was no evidence of NOESY correlations between H-2 and 
H-7, although such information must be interpreted with caution. Structure 7a was modeled 
using ChemBio3D Ultra with MM2 software for energy minimization to an RMS gradient of 
0.100 (Figure 3b). Based on the measured dihedral angles, diagnostic 3JH-C values were 
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predicted by application of the Karplus equation, and revealed that stereoisomer 7a should 
give a medium 3JH8-C4 value (4-5 Hz) and small couplings (0-3 Hz) from H-8 to Me-10 and to 
Me-11.21 The 3JH-C values in acremine P were measured using the pulse sequence EXSIDE;22 
the observed 3JH8-C4 of 5.4 Hz and small 3JH-C values (<1.5 Hz) to C-10 and C-11 were fully 
consistent with stereoisomer 7a.  
Also isolated from the large scale extract of A. persicinum was acremine Q (8) with a 
molecular formula of C12H18O5 indicated by HRESIMS. The 1H and 13C NMR spectra 
revealed a saturated ketone (δC 205.3 (s)), an acetal (δC 102.7 (s)), an epoxy group [δH 3.51 
(1H); 66.0 (d), 60.7 (s)], an oxymethine (δH 3.98; δC 86.2) and one other oxygenated carbon 
(δC 71.3). Three methyl groups at δH 1.44, 1.14, and 1.32 were linked to signals at δC 14.7, 
25.3, and 27.7 by HSQC, respectively. Because the molecular formula implied two rings, a 
comparison of HMBC data with those of 7 was undertaken, leading to the planar structure 
suggested. Key HMBC correlations included from the epoxy proton (H-5) to C-3, C-4, C-6, 
and to Me-12, from H-8 to C-3 and C-4, and from H-7 to C-4 and C-9. The signal for H-7a, 
which was obscured by the H2O peak in the 1H NMR spectra recorded in CDCl3, was 
detected when the spectrum was rerun in acetone-d6 or in benzene- d6. In acetone-d6, signals 
for the hydroxy groups at C-4 and C-9 were observed at δH 5.73 and 3.87, respectively. 
The relative configuration was suggested from a combination of NOESY data, 
molecular modeling, and coupling constant values. Only diastereomers with a (5S, 6R) 
configuration were considered on the reasonable expectation that 8 would share the same 
configuration at C-6 as other acremines. In CDCl3, H-3 showed couplings of 7.5, 6.0, 7.4 and 
4.4 Hz to H-2a, H-2b, H-7a, and H-7b, respectively, that suggested an equatorial rather than 
an axial orientation for H-3. On stereoelectronic grounds, the C-4 OH was anticipated to be 
axial. As a consequence of the flexible nature of the cis-fused ring junction, the coupling 
constant values for H-3 represented conformationally-averaged values. A key piece of 
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information was a pronounced NOESY correlation between H-2b and H-8. Four possible 
diastereomers 8a-8d with a cis ring junction were considered (Figure 4a), and minimum 
energy conformations calculated using ChemBio3D Ultra with MM2 software for energy 
minimization to an RMS gradient of 0.100. Stereoisomers 8a and 8d had inter-proton 
distances of 2.4 Å and 2.7 Å between H-2b and H-8, respectively; for each of the two 
diastereomers 8b–8c, the inter-proton distance was >4 Å. NOESY correlations between H-
2b/H-7b, H-7a/Me-11, and H-7b/Me-11) were in complete agreement with either 8a or 8d. 
Candidate diastereomers 8a and 8d were modelled using Macromodel version 9.9 (New 
York)23 and the structures further optimized with Gaussian version 09 (Wallingford),24 
resulting in 12 and 8 conformations within 3 kcal/mol of the global energy minimum for 8a 
and 8d, respectively. The Boltzmann-weighted chemical shifts were calculated, but the 
values for 8a and 8d were similar and neither set could not be conclusively assigned to 
acremine Q. However the Boltzmann weighted proton NMR coupling constants calculated in 
vacuum using the method of Jain et al.25 gave values that supported 8a as the preferred 
diasteromer. (see Table S3 in Supporting Information). The noticeable difference in chemical 
shift values for the Me-10 and Me-11 signals (δH 1.32 and 1.14 in CDCl3) may be a 
consequence of the hydrogen bonding between the C-4 and C-9 hydroxy groups. The  
 
 
 
 
 
 
 
 
Figure 4. a, Candidate diastereomers of acremine Q; b, Energy-minimized model structures 
of preferred diastereomer of acremine Q (8a) showing observed NOESY correlations. 
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absolute configuration of acremine Q was assigned (3R, 4R, 5S, 6R, 8R) as shown in 8. 
Attempted reduction of acremine Q using Pd/C in EtOAc led to a mixture of products in 
insufficient quantity for individual identification. 
Acremine R (9) was isolated as a colorless oil from RP-HPLC and had the same 
molecular formula C12H16O3 as that for acremine N (3) from HRESIMS measurements. The 
1H and 13C NMR spectra of this compound also revealed a close relationship to acremine N, 
notably the signals for a tetrasubstituted benzene ring [δH 6.61 (1H), 6.49 (1H); δC 147.8 (s), 
146.3 (s), 123.7 (s), 119.2 (d), 116.8 (s), and 115.6 (d)], a quaternary carbon (δC 76.3), one 
oxymethine (δH 3.73, δC 69.8), one methylene group (δH 2.99, 2.69; δC 31.3) and three methyl 
singlets (δH 2.17, 1.34, 1.27; δC 15.7, 22.6, 24.5). Two methyl groups (δH 1.34, 1.27) and the 
oxymethine showed HMBC correlations to the quaternary carbon at δC 76.3, assigned as C-9. 
The downfield chemical shift of C-9 suggested a chromane ring.26 The signal at δC 69.8 was 
assigned as C-8 based on HMBC correlations to Me-10 (δH 1.34), Me-11 (δH 1.27) and to the 
methylene group (δH 2.99, 2.67). A DQFCOSY experiment located the hydroxy group (δH 
1.75 d, 8.0) at C-8. When 9 was converted to its (R)- and (S)-O-methyl mandelate (MPA) 
esters 19a and 19b, the ∆δRS values (where ∆δRS = δR - δS) were positive for H-2 and H2-7 
and negative for H-5, Me-10, Me-11 and Me-12. These data supported an 8R configuration. 
Also isolated from the fungal extract was acremine N (3) with 1H and 13C NMR data identical 
to those reported by Nasini and co-workers. The [α]D was measured as +15, in reasonable 
agreement with the literature value ([α]D +35). Based on a comparison of its ECD data with 
those of other 2,3-dihydrobenzofurans, Nasini et al proposed that (+)-acremine N has an 8S 
configuration.14  
 
CONCLUSIONS 
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This study reported six new acremine metabolites, 5-chloroacremine A (4), 5-
chloroacremine H (5), acremines O (6), P (7), Q (8), and R (9), together with the known 
acremines A (1), F (2), and N (3). The relative configuration of acremine F (2) was 
determined by analyses of proton coupling constant values and NOESY data, and the 
absolute configuration confirmed as (1S, 4S, 6R) by X-ray crystallographic analysis of borate 
ester 15. Acremines O, P and R were all shown to be of 8R configuration by MPA ester 
determination. The relative configurations of acremines P and Q were each investigated by 
molecular modeling together with NOESY and coupling constant data. 
 
EXPERIMENTAL SECTION 
 General Experimental Procedures. These have been reported previously.27 NMR 
spectra were recorded at ambient probe temperature on a Bruker Avance 500 spectrometer 
unless otherwise stated. EXSIDE22 data were acquired on a 750 MHz Bruker Avance NMR 
spectrometer. In this two-dimensional experiment, a selective pulse was centered on the 
single proton of interest (H-8 of 7) such that proton-coupled peaks were not excited. Cross-
peaks appeared as doublets at the frequency of the coupled carbon resonances in F1. A 
J-scaling factor of 15 was applied to increase the magnitude of the splitting in F1, and this 
enabled couplings to be obtained with a resolution of ±0.6 Hz. 
 Biological Material. Sponge specimens were collected at the Gneering reef offshore 
from Mooloolaba, QLD in December 2009. The sponges were cut into small pieces, rinsed 
three times with sterile artificial seawater (ASW, Ocean Nature), and then cut into smaller 
cubes. Individual cubes were smeared across malt extract and potato dextrose agar (PDA) 
media, or were shaken with sterile glass beads in a Falcon tube containing sterile ASW (5 
mL). The cell suspension was then spread onto plates containing malt extract and PDA using 
a sterile cotton bud. The plates were then incubated at 27 ºC for 1-2 weeks. Individual fungal 
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strains were isolated, and streak purified onto new media several times. Fungal identification 
was undertaken using the Colony Polymerase Chain reaction performed with an Eppendorf 
MasterCycler Epgradient 28 (Eppendorf). Standard reaction mixes contained 0.25 μL of each 
primer designed to amplify the conserved rDNA ITS, 5 μL template DNA in distilled H2O, 
2.5 μL of 10× Buffer, 2 μL dNTPs and 0.125 μL Taq polymerase and added distilled H2O to 
make 25 μL of total volume. PCR products were electrophoresed on 1× TAE 1% agarose 
gels, stained with ethidium bromide and visualized on a UV transilluminator. The PCR 
products were purified using a QIAquick Gel Extraction Kit (QIAGEN GmbH, Hilden DE), 
then sent to the Australian Genome Research Facility (AGRF) for sequencing (GenBank 
accession number KF 017582) 
 Small Scale Fermentation. Cultures (50 mL) of A. persicinum were cultivated in malt 
extract media made in artificial seawater, and were kept in a shaker incubator (180 rpm) at 28 
°C for 2 weeks. The culture broths were separated from the mycelia by filtration, and then 
extracted with EtOAc (3 x 50 mL). The organic layers were collected and dried over 
anhydrous MgSO4, then concentrated under reduced pressure to afford brown extracts. The 
EtOAc extract (30 mg) was then subjected to NP flash column chromatography, eluting with 
hexanes/EtOAc in order of increasing polarity to give acremine A (1) (4.3 mg) and 
spiroacremine B (12)17 (1.9 mg).  
 Large Scale Fermentation. The isolated strain of A. persicinum was cultured in malt 
extract media (4 L) made in artificial seawater in a shaker incubator (180 rpm) at 28 °C for 4 
weeks. Culture medium and mycelia were then separated by filtration, and then the broth was 
extracted with EtOAc (3 x 2 L). The aqueous layer was further extracted with n-BuOH (3 x 
1L). The collected organic layers were then dried over anhydrous MgSO4 and concentrated 
under vacuo to obtain EtOAc (0.3 g) and BuOH (0.5 g) extracts. The EtOAc and BuOH 
extracts had a very similar profile by NMR and TLC and were combined for chemical 
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investigation. The combined extract (0.8 g) was subjected to NP flash column 
chromatography, using a stepwise elution with hexanes/EtOAc to afford 14 fractions. 
Fraction 6 was subjected to NP-HPLC using RI detection, eluting with 25% EtOAc/hexanes, 
flow rate 2 mL/min over 40 min to obtain acremine O (6) (0.8 mg). Fraction 7 was purified 
through NP-HPLC using the same procedure as for fraction 6, and yielded acremine N (3) 
(2.1 mg). Fractions 8 and 9 (45 mg) were combined and subjected to NP-HPLC, employing 
40% EtOAc/hexanes, flow rate 2 mL/min over 40 min to afford acremine N (3) (2.4 mg), 
together with a mixture of acremine R (9) and spiroacremine A (11) (7.5 mg), then a fraction 
containing acremine P (7) (3.0 mg), and finally acremine Q (8) (1.7 mg) in order of elution. 
The mixture of 9 and 11 was further purified by RP-HPLC using gradient elution from 60-
80% MeOH/H2O (20 min), followed by isocratic 80% MeOH/H2O (10 min), flow rate 1.5 
mL/min, and yielding spiroacremine A (11) (1.1 mg) and acremine R (9) (1.1 mg) in order of 
elution. The fraction containing acremine P (3.0 mg) was purified with NP HPLC using 
isocratic EtOAc/Hex (30:70), flow rate 2 mL/min, yielding 7 (1.1 mg). Fractions 11-13 of the 
NP flash column chromatography were combined (0.7 g) and subjected to NP-flash column 
chromatography, eluting with CH2Cl2/MeOH in order of increasing polarity to yield six 
fractions coded F13-1 to F13-7. Fraction F13-2 (259 mg) was further chromatographed on 
NP-flash column employing hexanes/EtOAc in order of increasing polarity to obtain nine 
fractions. Acremine A (1) (137 mg) was identified in fraction five, while the third fraction 
(3.8 mg) was purified on RP-HPLC using gradient elution from 10-40% MeOH/H2O (20 
min), followed by isocratic 40% MeOH/H2O (20 min), flow rate 1.5 mL/min, UV 254 nm to 
obtain a mixture of 5-chloroacremine H (5), 5-chloroacremine A (4) (0.5 mg) and 9-O-methyl 
acremine F (10) (1.5 mg) in order of elution. 5-Chloroacremine A (4) decomposed to 5-
chlorospiroacremine (16) during storage in CDCl3 for NMR analysis. Fraction F13-3 (154 
mg) was also subjected to RP-HPLC employing isocratic 15% MeCN/H2O (20 min), 
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followed by a gradient of 15-30% MeCN/H2O (10 min), then isocratic 30% MeCN/H2O (10 
min), flow rate 1.5 mL/min to obtain acremine A (1) (22.3 mg), acremine F (2) (13.9 mg) and 
9-O-methyl acremine F (10) (17.7 mg) in order of elution.  
 Acremine A (1):1 colorless needles (137 mg); [α]24D +13 (c 2.52, MeOH), Lit1 +22.3 (c 
0.04, MeOH); 1H and 13C NMR see Table 1 and Table 2; HRESIMS m/z 249.1102 [M+Na]+ 
(calcd for C12H18NaO4, 249.1097).   
 Acremine F (2):1 yellow oil (19.2 mg); [α]24D +38 (c 0.47, CHCl3), Lit1 +56 (c 0.2, 
CHCl3); 1H and 13C NMR see Table 1 and Table 2; LRESIMS m/z 251.2 [M+Na]+. 
 Acremine N (3):14 brown oil (2.1 mg); [α]24D +15 (c 0.08, CHCl3), Lit +35 (c 0.2, 
MeOH); 1H and 13C NMR  see ref 14; LRESIMS m/z 231.1 [M+Na]+.  
 5-Chloroacremine A (4): colorless oil (0.5 mg) mixture with 5; 1H and 13C NMR see 
Table 1 and Table 2; HRESIMS m/z 283.0716 [M+Na]+ (calcd for C12H17ClO4Na, 183.0708).  
 5-Chloroacremine H (5): colorless oil (0.5 mg) mixture with 4; 1H and 13C NMR see 
Table 1 and Table 2; HRESIMS m/z 299.0645 [M+Na]+ (calcd for C12H17ClO5Na, 299.0657).  
 Acremine O (6): colorless oil (0.8 mg); [α]24D  -8 (c 0.02, CHCl3); 1H and 13C NMR see 
Table 1 and Table 2; HRESIMS m/z 281.0565 [M+Na]+ (calcd for C12H15O4ClNa, 281.0551).  
 Acremine P (7): colorless oil (1.1 mg); α]24D  -43 (c 0.05, CHCl3); 1H and 13C NMR see 
Table 1 and Table 2; HRESIMS m/z 277.0673 [M+Na]+ (calcd for C12H14O6Na, 277.0683).  
 Acremine Q (8): colorless oil (1.7 mg); [α]24D  -12 (c 0.08, CHCl3); 1H and 13C  NMR 
(CDCl3) see Table 1 and Table 2; HRESIMS m/z 265.1042 [M+Na]+ (calcd for C12H18O5Na, 
265.1046). 
 Acremine R (9): colorless oil (1.5 mg); [α]24D  -8 (c 0.1, CHCl3); 1H and 13C NMR see 
Table 1 and Table 2; HRESIMS m/z 231.0991 [M+Na]+ (calcd for C12H16O3Na, 231.09992).  
 9-O-Methyl Acremine F (10): yellow oil (17.7 mg); [α]24D  +38 (c 1.27, CHCl3); 1H 
NMR (CDCl3, 500 MHz) δ 6.09 (1H, d, J = 16.0, H-7), 5.90 (1H, d, J = 16.0, H-8), 5.61 (1H, 
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d, J = 2.5, H-2), 4.43 (1H, m, H-4), 3.99 (1H, dd, J = 9.0, 2.5, H-1), 3.59 (1H, s, 6-OH), 3.48 
(1H, d, J = 7.5, 4-OH), 3.16 (3H, s, OMe), 2.85 (1H, d, J = 9.0, 1-OH), 2.22 (1H, dd, J = 
15.0, 2.0, H-5a), 1.80 (1H, dd, J = 15.0, 4.0, H-5b), 1.31 (3H, s, Me-12), 1.30 (6H, s, Me-11 
and Me-10; 13C NMR (CDCl3, 125 MHz) δ 137.7 (C-3), 136.0 (C-8), 130.5 (C-2), 128.7 
(C-7), 75.2 (C-9), 73.0 (C-1), 71.0 (C-6), 64.1 (C-4), 50.6 (OMe), (26.8 (Me-12), 26.0 (Me-
10 and Me-11); HRESIMS m/z 265.1422 [M+Na]+ (calcd for C13H22O4Na, 265.1410).  
  Spiroacremine A (11):17 white solid (1.4 mg); [α]24D  +15 (c 0.09, CHCl3), Lit19 +18 
(c 0.3, EtOH); 1H and 13C NMR see ref 17; HRESIMS m/z 249.1125 [M+Na]+ (calcd for 
C12H18O4Na, 249.1097).  
 Spiroacremine B (12):17 yellow oil (4.7 mg); [α]24D  -17 (c 0.18, CHCl3), Lit19 +4.2 (c 
0.24, EtOH); 1H and 13C NMR see ref 17; HRESIMS m/z 249.1100 [M+Na]+ (calcd for 
C12H18O4Na, 249.1097).  
 5-Chlorospiroacremine (16): colorless oil (0.5 mg) mixture with 4 and 5; 1H NMR 
(CDCl3, 500 MHz) δ 6.70 (1H, d, J = 16.0, H-8), 6.49 (1H, d, J = 16.0, H-7), 6.18 (1H, d, J = 
1.8, H-2), 4.60 (1H, m, H-4), 4.23 (1H, d, J = 8.2, H-5), 2.90 (1H, d, J = 4.8, 4-OH), 1.404 
(3H, s, Me-10), 1.400 (3H, s, Me-11), 1.39 (3H, s, Me-12); 13C NMR (CDCl3, 500 MHz) δ 
198.3 (C-1), 156.2 (C-3), 149.2 (C-8), 122.7 (C-7), 121.5 (C-2), 75.9 (C-6), 72.2 (C-4), 71.3 
(C-9), 70.4 (C-5), 29.6 (2C, Me-10 & Me-11), 21.0 (C-12).    
 Reduction of Acremine A with NaBH4. Acremine A (1) (7.0 mg) dissolved in EtOH (1 
mL) was treated with NaBH4 (1.3 mg, 1.1 equiv) at room temperature (rt). After 1 h, 1 mL 
acetone was added, followed by H2O (2 mL), and extraction with EtOAc (3 x 2mL). The 
organic layer was then collected, dried over MgSO4 and concentrated under vacuo to obtain a 
mixture of acremine F (2) and 1-epi-acremine F (13) in a 2:1 ratio. The mixture (5 mg) was 
then subjected to RP-HPLC, UV 254 nm, using isocratic 15% MeCN/H2O (25 min), flow rate 
1.5 mL/min to yield acremine F (2.0 mg) and 1-epi-acremine F (0.7 mg).  
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 1-epi-Acremine F (13): colorless oil (0.7 mg); [α]24D  -18 (c 0.05, CHCl3); 1H NMR 
(CDCl3, 500 MHz) δ 6.24 (1H, d, J = 16.1, H-7), 6.16 (1H, d, J = 16.1, H-8), 5.88 (1H, d, J = 
4.8, H-2), 4.49 (1H, ddd, J = 7.0, 4.4, 3.0, H-4), 3.92 (1H, br t, J = 5.4, H-1), 2.75 (1H, d, J = 
7.0, 4-OH), 2.59 (1H, s, 6-OH), 2.01 (1H, J = dd, 14.4, 4.4, H-5a), 1.96 (1H, ddd, J = 14.4, 
3.3, 1.1, H-5b), 1.53 (1H, d, J = 6.3, 1-OH), 1.38 (3H, s, Me-10), 1.37 (3H, s, Me-11), 1.36 
(3H, s, Me-12); LRESIMS m/z 251.2 [M+Na]+.  
 Preparation of p-Bromophenylboronate and Borate Esters of 9-O-Methyl Acremine 
F. 9-O-Methyl-acremine F (10) (2.6 mg) was treated with p-bromophenyl boronic acid (2.4 
mg, 1.1 equiv) in CH2Cl2 (1 mL) at rt. After 24 h, the sample was evaporated under N2 to 
obtain a mixed ester product (4.4 mg) containing the p-bromophenylboronate ester of 9-O-
methyl-acremine F (14). The mixture was then subjected to NP-pipette column 
chromatography, employing gradient elution with hexanes/EtOAc to obtain nine fractions. 
Fractions 7 to 9 were combined (2.1 mg) to give a mixture of the boronate ester 14 and the 
borate ester 15 in a 3:2 ratio. This sample was subjected to recrystallization without further 
purification in EtOAc using the vapor diffusion method yielding single crystals of the borate 
ester 15. 
 p-Bromophenylboronate Ester of 9-O-Methyl Acremine F (14): white amorphous 
solid; 1H NMR (CDCl3, 500 MHz) δ 7.62 (2H, m, Ph), 7.47 (2H, m, Ph), 6.06 (2H, s, H-7 and 
H-8), 5.61 (1H, d, J = 2.5, H-2), 4.81 (1H, t, J = 2.7, H-4), 4.14 (1H, dd, J = 11.7, 2.5, H-1), 
3.18 (3H, s, OMe), 2.18 (1H, dd, J = 14.0, 3.3, H-5a), 2.16 (1H, d, J = 11.7, 1-OH), 2.04 (dd, 
J = 14.0, 2.4, H-5b), 1.54 (3H, s, Me-12), 1.33 (3H, s, Me-10), 1.33 (3H, s, Me-11); 13C 
NMR (CDCl3, 500 MHz) δ 138.5 (C-3), 136.8 (C-8), 135.5 (Ph), 131.0 (Ph), 130.8 (Ph), 
130.1 (C-2), 127.9 (C-7), 125.9 (Ph), 75.0 (C-9), 74.7 (C-1), 72.6 (C-6), 63.4 (C-4), 50.5 
(OMe), 38.5 (C-5), 26.4 (C-11), 25.2 (C-10), 25.1 (C-12). LRESIMS m/z 429.2/431.1 
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[M+Na]+, 445.1/457.1 [M+K]+. HRESIMS m/z 429.0858/431.0848 [M+Na]+ (calcd for 
C19H24BBrO4Na, 429.0849/431.0828). 
 Borate Ester of 9-O-Methyl Acremine F (15): colorless crystals; 1H NMR (CDCl3, 500 
MHz) δ 6.10 (1H, d, J = 16.4, H-7), 5.92 (1H, d, J = 16.4, H-8), 5.63 (1H, d, J = 2.5, H-2), 
4.47 (1H, m, H-4), 4.01 (1H, dd, J = 8.8, 2.5, H-1), 3.17 (3H, s, OMe), 2.56 (1H, dd, J = 14.9, 
2.2, H-5a), 2.41 (1H, d, J = 8.8, 1-OH), 1.82 (dd, J = 14.9, 4.3, H-5b), 1.33 (3H, s, Me-12), 
1.314 (3H, s, Me-10), 1.309 (3H, s, Me-11); 13C NMR (CDCl3, 500 MHz) δ 137.6 (C-3), 
136.1 (C-8), 130.4 (C-2), 128.5 (C-7), 75.0 (C-9), 72.9 (C-1), 70.7 (C-6), 64.0 (C-4), 50.5 
(OMe), 40.4 (C-5), 26.7 (C-12), 26.0 (C-10), 26.0 (C-11). LRESIMS m/z 291.1 [M+Na]+; 
HRESIMS m/z 291.1350 [M+Na]+ (calcd for C13H21BO5Na, 291.1374).  
 Crystallographic Data of the Borate Ester 15: C13H21BO5, M 268.11, T 293(2) K, 
monoclinic, space group C 2, a 22.3089 (7) Å, b 7.0719 (2) Å, c 9.8434 (3) Å, V 1486.28 (8) 
Å3, Dc (Z = 4) 1.198 g cm-3, F(000) 576, μ(Cu-Kα) 0.738 mm-1, 10093 data (2θmax = 62°), 
Rint 0.0204, 2282 with I>2σ(I); R 0.0248 (obs. data), wR2 0.0659 (all data), goodness of fit 
1.068. CCDC number 928199. Data were collected on an Oxford Diffraction Gemini CCD 
diffractometer with Cu-Ka radiation (1.5418 Å). The structure was solved by direct methods 
and refined with SHELX.28 A complete sphere of data were collected and the absolute 
structure was determined by analysis of 1001 Bijvoet pairs using the method of Hooft et al.29 
implemented within PLATON.30 The probability of the correct enantiomer (P2) was 1.000 
using Student’s t-statistics with a ν value of 10 and a Hooft parameter of -0.01(6). All 
calculations were carried out within the WinGX31 program and the thermal ellipsoid plot 
(Figure 2) was produced with ORTEP3.32 
 Preparation of MPA Esters of Acremine O (17a/17b), Acremine P (18a /18b) and 
Acremine R (19a/19b). Acremine O (6) (0.6 mg) was divided into two portions, and each 
sample (approximately 0.3 mg) was treated with either (R)- or (S)-MPA (0.4 mg, 2 equiv), 
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followed by DCC (0.5 mg, 2 equiv) and DMAP (0.3 mg, 2equiv) in dry CH2Cl2 (0.5 mL). 
The reaction was stirred overnight at rt, which was then filtered through a small plug of silica 
eluting with CHCl3. The solvent was then dried in vacuo, and each product was then purified 
by RP-HPLC, eluting with 60-100% MeCN/H2O for 35 min, flow rate 1.5 mL/min to yield 
the (R)-MPA ester (17a) (0.2 mg) and (S)-MPA ester (17b) (0.2 mg). A portion of acremine P 
(7) was likewise divided into two, and each sample (approximately 0.4 mg) was treated with 
either (R)- or (S)-MPA, using the same procedures for 6 to obtain the (R)-MPA ester (18a) 
(0.4 mg) and (S)-MPA ester (18b) (0.4 mg). A portion of acremine R (9) (0.5 mg each) was 
reacted with either (R)- or (S)-MPA using the same procedure as for 6 and 7 to obtain the (R)-
MPA ester (19a) (0.3 mg) and (S)-MPA ester (19b) (0.3 mg). 
 (R)-MPA Ester (17a): colorless oil; 1H NMR (CDCl3, 500 MHz) δ 7.46 - 7.35 (5H, m, 
MPA phenyl protons), 5.16 (1H, dd, J = 5.8, 2.0, H-8), 4.79 (1H, CH of MPA), 3.43 (3H, s, 
OMe of MPA), 3.22 (1H, dd, J = 14.6, 5.8, H-7a), 3.12 (1H, d. J = 16.1, H-2a), 2.89 (1H, d, J 
= 16.1, H-2b), 2.15 (3H, s, Me-12), 1.80 (1H, dd, J = 14.6, 2.0, H-7b), 1.08 (3H, s, Me-10), 
0.80 (3H, s, Me-11); LRESIMS m/z 429.2 [M+Na]+.  
 (S)-MPA Ester (17b): colorless oil; 1H NMR (CDCl3, 500 MHz) δ 7.46 - 7.35 (5H, m, 
MPA phenyl protons), 5.15 (1H, dd, J = 5.8, 1.5, H-8), 4.80 (1H, CH of MPA), 3.42 (3H, s, 
OMe of MPA), 3.19 (1H, dd, J = 15.0, 5.8, H-7a), 2.73 (1H, d. J = 16.3, H-2a), 2.51 (1H, d, J 
= 16.3, H-2b), 2.13 (3H, s, Me-12), 1.48 (1H, dd, J = 15.0, 1.5, H-7b), 1.18 (3H, s, Me-10), 
1.13 (3H, s, Me-11); LRESIMS m/z 429.2 [M+Na]+.  
 (R)-MPA Ester (18a): colorless oil; 1H NMR (CDCl3, 500 MHz) δ 7.48-7.37 (5H, 
phenyl protons), 6.603 (1H, s, H-7), 5.22 (1H, s, H-2), 4.83 (1H, s, CH of MPA), 4.17 (1H, s, 
H-8), 3.44 (3H, s, OMe of MPA), 1.51 (3H, s, Me-12), 1.45 (3H, s, Me-10), 1.42 (3H, s, 
Me-11); LRESIMS m/z 425.0 [M+Na]+.  
 24 
 (S)-MPA Ester (18b): colorless oil; 1H NMR (CDCl3, 500 MHz) δ 7.48-7.38 (5H, 
phenyl protons), 6.597 (1H, s, H-7), 5.19 (1H, s, H-2), 4.82 (1H, s, CH of MPA), 4.34 (1H, s, 
H-8), 3.43 (3H, s, OMe of MPA), 1.45 (3H, s, Me-12), 1.48 (3H, s, Me-10), 1.47 (3H, s, 
Me-11); LRESIMS m/z 425.0 [M+Na]+.  
 (R)-MPA Ester (19a): colorless oil; 1H NMR (CDCl3, 500 MHz) δ 7.43-7.30 (5H, m, 
phenyl protons), 6.58 (2H, br s, H-2 and H-5), 4.92 (1H, t, J = 5.5, H-8), 4.75 (1H, CH of 
MPA), 3.50 (3H, s, OMe of MPA), 3.03 (1H, dd, J = 17.3, 5.5, H-7a), 2.71 (1H, dd, J = 17.3, 
5.5, H-7b), 1.75 (3H, s, Me-12), 1.02 (3H, s, Me-10), 0.92 (3H, s, Me-11); LRESIMS m/z 
379.1 [M+Na]+.  
 (S)-MPA Ester (19b): colorless oil; 1H NMR (CDCl3, 500 MHz) δ 7.43-7.30 (5H, m, 
phenyl protons), 6.59 (1H, s, H-5), 6.37 (1H, s, H-2), 4.98 (1H, t, J = 5.1, H-8), 4.75 (1H, CH 
of MPA), 3.50 (3H, s, OMe of MPA), 3.87 (1H, dd, J = 17.2, 5.1, H-7a), 2.32 (1H, dd, J = 
17.2, 5.1, H-7b), 1.78 (3H, s, Me-12), 1.28 (3H, s, Me-10), 1.23 (3H, s, Me-11); LRESIMS 
m/z 379.1 [M+Na]+.  
 Catalytic Hydrogenation of Acremine P (7) and Acremine Q (8). Acremine P (7) (0.7 
mg) was first dried under N2 followed by high vacuum treatment overnight. The round 
bottom flask (5 mL) containing the sample was flushed with N2 for about 2 min. Dry EtOAc 
(2 mL) was then added, and reaction flushed with H2 gas for 2 min. Catalyst Pd/C (1.3 mg) 
was then added, and the reaction flushed with H2 gas for about 5 min to remove air. After 
22h, the product was filtered through a short plug of celite eluting with EtOAc (15 mL). The 
collected product was then dried under N2. When 1H NMR showed that no reaction had 
occurred, hydrogenation was carried out for a further 24 h under the same conditions. The 
reaction was filtered through celite eluting with EtOAc to give acremine A (1), which was 
purified by RP HPLC, using a gradient elution of MeCN/H2O to obtain acremine A (1) (0.5 
 25 
mg). Acremine Q (0.5 mg) was treated similarly, but the reaction product (0.5 mg) obtained 
contained a mixture of products. 
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